Moderna Net Income From Continuing Ops from 2010 to 2026

0QF Stock  EUR 44.24  1.45  3.39%   
Moderna's Net Loss is decreasing over the last several years with very volatile swings. Net Loss is estimated to finish at about -3.9 B this year. During the period from 2010 to 2026 Moderna Net Loss regressed destribution of quarterly values had mean deviationof  2,407,000,062 and mean square error of 18993037.8 T. View All Fundamentals
 
Net Loss  
First Reported
2019-09-30
Previous Quarter
-825 M
Current Value
-200 M
Quarterly Volatility
1.9 B
 
Covid
 
Interest Hikes
Check Moderna financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Moderna's main balance sheet or income statement drivers, such as Net Interest Income of 484.2 M, Interest Income of 513.2 M or Interest Expense of 15.3 M, as well as many indicators such as Price To Sales Ratio of 5.61, Dividend Yield of 4.0E-4 or PTB Ratio of 1.26. Moderna financial statements analysis is a perfect complement when working with Moderna Valuation or Volatility modules.
  
This module can also supplement various Moderna Technical models . Check out the analysis of Moderna Correlation against competitors.
For more detail on how to invest in Moderna Stock please use our How to Invest in Moderna guide.
The Net Income From Continuing Ops trend for Moderna offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Moderna is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Moderna's Net Income From Continuing Ops Growth Pattern

Below is the plot of the Net Income From Continuing Ops of Moderna over the last few years. It is Moderna's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Moderna's overall financial position and show how it may be relating to other accounts over time.
Net Income From Continuing Ops10 Years Trend
Very volatile
   Net Income From Continuing Ops   
       Timeline  

Moderna Net Income From Continuing Ops Regression Statistics

Arithmetic Mean52,249,735
Coefficient Of Variation8,105
Mean Deviation2,407,000,062
Median(216,211,000)
Standard Deviation4,234,799,490
Sample Variance17933526.7T
Range16.9B
R-Value(0.08)
Mean Square Error18993037.8T
R-Squared0.01
Significance0.75
Slope(70,725,583)
Total Sum of Squares286936427.6T

Moderna Net Income From Continuing Ops History

2026-3.9 B
2025-4.1 B
2024-3.6 B
2023-4.7 B
20228.4 B
202112.2 B
2020-747.1 M

About Moderna Financial Statements

Moderna stakeholders use historical fundamental indicators, such as Moderna's Net Income From Continuing Ops, to determine how well the company is positioned to perform in the future. Although Moderna investors may analyze each financial statement separately, they are all interrelated. For example, changes in Moderna's assets and liabilities are reflected in the revenues and expenses on Moderna's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Moderna. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Loss-4.1 B-3.9 B

Currently Active Assets on Macroaxis

When determining whether Moderna offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Moderna's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Moderna Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Moderna Stock:
Check out the analysis of Moderna Correlation against competitors.
For more detail on how to invest in Moderna Stock please use our How to Invest in Moderna guide.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Understanding that Moderna's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Moderna represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Moderna's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.